Search Results 121-130 of 14718 for infliximab

  1. Aminophylline (intravenous route) - Mayo Clinic

    Infliximab; Isoniazid; Ketamine; Leniolisib; Levofloxacin; Levonorgestrel; Medroxyprogesterone. Show More. Using this medicine with any of the following ...

  2. A Study to Evaluate the Safety and Effectiveness of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

    Infliximab: at least 14 weeks treatment at the approved doses for induction and/or maintenance in Crohn´s disease prior to screening for the study. For ...

  3. A Study to Evaluate the Effectiveness and Safety of Risankizumab in Subjects with Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    At least one 6-week induction regimen of infliximab (≥ 5 mg/kg intravenous [IV] ... approved biologic agent (e.g., infliximab, adalimumab, golimumab ...

  4. Irinotecan (intravenous route) - Mayo Clinic

    This medicine is also given to patients with metastatic cancer of the colon or rectum who have received fluorouracil but disease has progressed or recurred.

  5. Sirolimus (topical application route) - Mayo Clinic

    Sirolimus topical gel is used to treat facial angiofibroma (type of noncancerous tumor) caused by a genetic condition called tuberous sclerosis. This medicine ...

  6. Aminophylline (oral route) - Mayo Clinic

    Infliximab; Isoniazid; Ketamine; Leniolisib; Levofloxacin; Levonorgestrel; Medroxyprogesterone. Show More. Using this medicine with any of the following ...

  7. Treatment of IgG4-Related Disease With Revlimid and Rituximab - Mayo Clinic

    Treatment with infliximab, adalimumab, or etanercept within the past 12 months. Currently taking azathioprine, 6-mercaptopurine, methotrexate, mycophenolate ...

  8. Upadacitinib (oral route) - Mayo Clinic

    Description. Upadacitinib is used to treat moderate to severely active rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, ...

  9. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

    Has not previously received an approved biologic for CD (i.e., infliximab, adalimumab, certolizumab pegol, ustekinumab, natalizumab, vedolizumab or approved ...

  10. Flibanserin (oral route) - Mayo Clinic

    Flibanserin is used to treat hypoactive sexual desire disorder (HSDD) in women who have not gone through menopause. This medicine should only be used by women ...